Søgning på udtrykket 'hepatitis' giver 107 resultater
Dokumenter [11] Sider [4] Kalender [50] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [11]
National guideline udarbejdet af en arbejdsgruppe nedsat af medlemmer fra Dansk Selskab for Infektionsmedicin og medlemmer fra Dansk Selskab for Gastroenterologi og Hepatologi.
National guideline udarbejdet af en arbejdsgruppe nedsat af medlemmer fra Dansk Selskab for Infektionsmedicin og medlemmer fra Dansk Selskab for Gastroenterologi og Hepatologi.
Diagnostik, behandling og forebyggelse af infektion med hepatitis A virus (HAV)
Forfattere: Jan Gerstoft, Nina Weis, Terese L. Katzenstein (Dansk Selskab for Infektionsmedicin), Anders Nyboe Andersen og Jens Fedder (Dansk Fertilitetsselskab).
Udarbejdet af en arbejdsgrupper bestående af medlemmer fra Dansk Selskab for Infektionsmedicin og Dansk Transplantationsselskab
Revideret september 2020. Arbejdsgruppen bestod af Suzanne Lunding (formand), Peer Brehm Christensen, Christian Erikstrup, Terese L. Katzenstein, Henrik Krarup, Alex Lund Laursen, Birgitte Mørn og Nina Weis
Program
Program og tilmelding
Ved Andrea Sinclair, SSI
Sider [4]
…At orientere DSI's bestyrelse ved nye medlemmer i gruppen, eller hvis medlemmer udgår efter ønske eller ved inaktivitet., Nedenfor vises selskabets repræsentanter i diverse arbejdsgrupper og udvalg, og publicerede guidelines. Akut viral hepatitis: Carsten Shade Larsen og Nina Weis. Hepatitis A (2013), Antiretroviral terapi: Henrik Nielsen, Jan Gerstoft, Jens Lundgren, Alex Laursen, Niels Obel, Isik Somuncu, Gitte Kronborg, Ann-Brit Eg Hansen Antiviral behandling af…
…ioner: Dato for næste kursus Efterår 2024 (2 dage) : Sted Endnu ikke afklaret Delkursusledelse Jakob Bodilsen og Lars Omland Tidligere kurser 11. og 12. april 2018 9. og 10 september 2021 Gastroenterologiske infektioner og kronisk hepatitis: Dato for næste kursus 2026: Sted Odense Universitetshospital Delkursusledelse Lone Mygind, Micha Jepsen og Belinda Mössner Tidligere kurser 4. og 5. december 2023 3. og 4. december 2020 HIV-infektion: Næste kursus Ef…
…ogiske oversigter (slides). www.natap.org/. National AIDS Treatment Advocacy Project ? en New York State non-profit NGO ledet af Jules Levin (som selv lever med Hiv og hepatitis). God side, hvis man mangler slides/figurer/tabeller fra studier præsenteret på senest afholdte konferencer kommer ofte med referat (inklusive Jules Levins fortolkning ud fra et patient/aktivist perspektiv). www.clinicaloptions.com/HIV.aspx. Et andet website for opdateringer og sammendrag af konferencer (slides).
Professor Henrik Nielsen kommenterer: I disse år sker et paradigmeskift i behandlingen af kronisk hepatitis C virus infektionen. Mange direkte virkende lægemidler er i afprøvning og med lovende resultater. Snart er interferon-baseret terapi ikke absolut nødvendig, mens oral terapi af kort varighed synes indenfor rækkevidde. Samtidigt er bivirkninger ved de nye lægemidler hidtil beskrevet som milde og sjældne. Kombination af sofosbuvir og ledipasvir i samme tablet bliver muligvis den første effektive…
Professor Nina Weis kommenterer: Kronisk hepatitis B, forårsaget af forekomst af hepatitis B virus i blodet i > 6 måneder, kan klinisk manifestere sig fra asymptomatisk til fibrose, cirrose og hepatocellulært carcinom. Trods forekomst af en effektiv vaccine i mere end 40 år, lever 296 millioner mennesker globalt med kronisk hepatitis B, heraf estimerede 14.500 i Danmark. Aktuelt er eneste behandlingstilbud (ofte livslang) antiviral terapi. Denne artikel gennemgår naturhistorien, kendte og nye biomark…
Kalender [50]
4. december, Odense Universitetshospital
27. oktober, Vandrehal lokale 3, Hvidovre Hospital
25. september, Hvidovre Hospital
7. juni, Rom, Italien
2. juni, Auditorium 3 og 4, Hvidovre Hospital
26. oktober 2022, Auditorium 3 and 4, Hvidovre Hospital
28. juli 2022, Globalt
17. juni 2022, Auditorium 3+4, Hvidovre Hospital
10. maj 2022, Auditorium 3+4, Hvidovre Hospital
25. marts 2021, Online
3. december 2020, Hvidovre Hospital
28. oktober 2020, Paris, Frankrig
17. september 2020, Auditorium 3-4, Hvidovre Hospital
25. november 2019, Auditorium 3 og 4, Hvidovre Hospital
25. september 2019, London, England
11. september 2019, DGI-byen, København
21. juli 2019, Mexico City, Mexico
22. maj 2019, Rom, Italien
10. maj 2019, Auditorium 3 og 4, Hvidovre Hospital
15. februar 2019, Auditorium, University of Southern Denmark, J. B. Winsløws Vej 25, Odense
24. januar 2019, Aarhus Universitetshospital
11. januar 2019, Aalborg
28. november 2018, Hvidovre Hospital
30. maj 2018, Rom, Italien
4. maj 2018, Hindsgavl, Middelfart
9. april 2018, Amsterdam, Holland
27. februar 2018, Hvidovre Hospital
12. december 2017, Auditorium 3 og 4, Hvidovre Hospital
14. september 2017, IDA Mødecenter, Kalvebod Brygge 31, 1560 København V
30. maj 2017, Hvidovre Hospital
31. januar 2017, Malta
13. oktober 2016, Auditoriet, Syddansk Universitet
25. maj 2016, Rom, Italien
3. juni 2015, Barcelona, Spanien
24. marts 2015, Auditorium 3+4, Hvidovre Hospital
13. november 2014, Auditorium 3-4, Hvidovre Hospital
24. oktober 2014, Rigshospitalet
9. oktober 2014, Frankfurt, Tyskland
18. juli 2014, Aud. 3 og 4, Hvidovre Hospital, Kettegård Allé 30, 2650 Hvidovre
5. juli 2014, Sigtuna, Sverige
23. maj 2014, Aud. 3 og 4, Hvidovre Hospital, Kettegård Allé 30, 2650 Hvidovre
1. maj 2014, Berlin, Tyskland
26. marts 2014, Barcelona, Spanien
30. juni 2013, Kuala Lumpur, Malaysia
20. marts 2013, Rom, Italien
3. marts 2013, Atlanta, Georgia, USA
25. oktober 2012, Danmarks Medie- og Journalisthøjskole
18. oktober 2012, Berlin, Tyskland
7. november 2011, Auditorium 93, Rigshospitalet
24. maj 2011, Rigshospitalet, København
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?BMC Infectious Diseases
9.12.2023
. Abstract. . Background and aims. Refugees are at higher risk for hepatitis B (HBV) and hepatitis C (HCV), but often face unique healthcare barriers to vaccination, testing, and treatment. This scoping review aimed to identify and characterize HBV and HCV prevention and care services serving refugee populations globally. . . . Methods. A li…
BMC Infectious Diseases
9.12.2023
…Abstract. . Background. Aberrant Wnt5a expression contributes to immunity, inflammation and tissue damage. However, it remains unknown whether Wnt5a is associated with liver injury in chronic hepatitis B virus (HBV) infection. We aimed to explore the potential role of Wnt5a expression in liver injury caused by chronic HBV infection. . . . Methods. Wnt5a mRNA le…
AIDS
9.12.2023
No abstract available
BMC Infectious Diseases
8.12.2023
…Abstract. . Background. Aberrant Wnt5a expression contributes to immunity, inflammation and tissue damage. However, it remains unknown whether Wnt5a is associated with liver injury in chronic hepatitis B virus (HBV) infection. We aimed to explore the potential role of Wnt5a expression in liver injury caused by chronic HBV infection. . . . Methods. Wnt5a mRNA le…
PLoS One Infectious Diseases
8.12.2023
by Nambusi Kyegombe, Gbolahan Ajibola, Maureen Sakoi-Mosetlhi, Tsholofelo Rebatenne, Motswedi Anderson, Simani Gaseitsiwe, Joseph Makhema, Una Ngwenya, Sikhulile Moyo, Odile Sauzet, Lucy Mupfumi .
BMC Infectious Diseases
3.12.2023
. Abstract. . Background. Whether different anti-hepatitis B virus (HBV) drugs have different effects on COVID-19 is controversial. We aimed to evaluate the incidence of COVID-19 in chronic hepatitis B (CHB) patients receiving anti-HBV treatment, and to compare the impact of entecavir (ETV) and tenofovir disoproxil fumarate (TDF) on the severity of COVID-19. . . . …
BMC Infectious Diseases
1.12.2023
. Abstract. . Background. Whether different anti-hepatitis B virus (HBV) drugs have different effects on COVID-19 is controversial. We aimed to evaluate the incidence of COVID-19 in chronic hepatitis B (CHB) patients receiving anti-HBV treatment, and to compare the impact of entecavir (ETV) and tenofovir disoproxil fumarate (TDF) on the severity of COVID-19. . . . …
PLoS One Infectious Diseases
30.11.2023
by Tamara Prinsenberg, Joël Illidge, Paul Zantkuijl, Maarten Bedert, Maria Prins, Marc van de r Valk, Udi Davidovich .
Proceedings of the National Academy of Sciences
29.11.2023
Proceedings of the National Academy of Sciences, Volume 120, Issue 49, December 2023.
Journal of Medical Virology
28.11.2023
Journal of Medical Virology, Volume 95, Issue 11, November 2023.
Journal of Medical Virology
28.11.2023
Journal of Medical Virology, Volume 95, Issue 11, November 2023.
Clinical Infectious Diseases
26.11.2023
AbstractBackgroundLong-term outcomes of tenofovir-containing antiretroviral therapy (ART) for HBV/HIV coinfection were evaluated in Zambia.MethodsA prospective cohort of adults with HIV and hepatitis B surface antigen (HBsAg)-positivity was enrolled at ART (included tenofovir DF + lamivudine) initiation. On therapy, we ascertained HBV viral load (VL) non-suppression, ALT elevation, serologic end-points, progression of liver fibrosis, based on elastography, and hepatocellular carcinoma (HCC) incidence. We al…
Clinical Infectious Diseases
26.11.2023
AbstractBackgroundWe aimed to evaluate the efficacy of opportunistic treatment of hepatitis C virus (HCV) infection among hospitalized people who inject drugs (PWID).MethodsWe performed a pragmatic, stepped wedge cluster randomized trial recruiting HCV RNA positive individuals admitted for inpatient care in departments of internal medicine, addiction medicine, and psychiatry at three hospitals in Oslo, Norway. Seven departments were sequentially randomized to change from control conditions (standard of care…
Journal of Medical Virology
24.11.2023
Journal of Medical Virology, Volume 95, Issue 11, November 2023.
Clinical Infectious Diseases
24.11.2023
BMC Infectious Diseases
17.11.2023
…ract. . Background. Healthcare utilization is typically adversely affected when the treatment is expensive and requires multiple visits. We examined the determinants of healthcare-seeking for Hepatitis C virus (HCV) infection which is asymptomatic, chronic, and requires costly treatment in an urban tertiary care referral hospital in Vietnam. . . . Methods. We c…
PLoS One Infectious Diseases
15.11.2023
…ating locally. This study conducted a population-genetics analysis to evaluate the genetic diversity of HBV among Kenyan blood donors. In addition, within the same cohort, the incidence and features of immune-associated escape mutations and stop-codons in Hepatitis B surface antigen (HBsAg) were determined. Methods In September 2015 to October 2016, 194 serum samples were obtained from HBsAg-positive blood donors residing in eleven different Kenyan counties: Kisumu, Machakos, Uasin Gishu, Nairobi, Nakuru, …
Virulence
9.11.2023
Volume 14, Issue 1, December 2023 .
PLoS One Infectious Diseases
6.11.2023
by Ibrahim A. Naqid, Ahmed A. Mosa, Shah Vahel Ibrahim, Nizar Hussein Ibrahim, Nawfal R. Hussein . Background and aims Healthcare staff are at high risk of occupational exposure to Hepatitis B and other blood-borne diseases. Lack of education about the knowledge of Hepatitis B virus contributes to an increase in cases. This study aims to determine the knowledge of the Hepatitis B virus among the medical professionals in Duhok province, Kurdistan Region of Iraq, and to determine their knowledge of the impor…
Journal of Medical Virology
3.11.2023
Journal of Medical Virology, Volume 95, Issue 11, November 2023.
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Medscape Infectious Diseases
1.12.2023
At least 450 patients at Mass General Brigham, Salem Hospital, near Boston are at risk of HIV and hepatitis infection, according to a lawsuit claiming negligent intravenous medication administration. . Medscape Medical News
Medscape Infectious Diseases
11.11.2023
A scientist whose work was key to identifying, studying, and finding treatments for this life-threatening virus discusses the scientific journey and challenges that persist. . Knowable Magazine
Morbidity and Mortality Weekly Report (MMWR)
1.11.2023
CDC reports on CDC recommendations for hepatitis C testing among perinatally exposed infants and children in the United States in 2023.
Medscape Infectious Diseases
20.10.2023
Despite ongoing hostilities, healthcare professionals take mobile clinics to their fellow Ukrainians, as the battle extends to fighting the country's high levels of hepatitis C. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
19.10.2023
This report describes deaths related to hepatitis A outbreaks.
Eurosurveillance latest updates
22.09.2023
On 5 April 2022, the United Kingdom reported an increase of cases of severe acute hepatitis of unknown aetiology in children, several needing hospitalisation and some required liver transplant or died. Thereafter, 35 countries reported probable cases, almost half of them in Europe. Facing the alert, on 28 April, Portugal created a multidisciplinary Task Force (TF) for rapid detection of probable cases and response. The experts of the TF came from various disciplines: clinicians, laboratory experts, epidemio…
Medscape Infectious Diseases
23.08.2023
Mortality rates remain substantially elevated after successful treatment of hepatitis C infection in the era of interferon-free antiviral therapy, a study of over 20,000 patients has found. . Medscape Medical News
Eurosurveillance latest updates
28.07.2023
. Background. The burden of chronic hepatitis B virus (HBV) varies across the European Union (EU) and European Economic Area (EEA). . . Aim. We aimed to update the 2017 HBV prevalence estimates in EU/EEA countries and the United Kingdom for 2018 to 2021. . . Methods. We undertook a systematic review, adding to HBV prevalence estimates from an existing (2005–2017) database. Databases were searched for original English-language research articles including HBV surface antigen prevalence estimates among t…
Eurosurveillance latest updates
28.07.2023
. Background. Georgia has adopted the World Health Organization European Region’s and global goals to eliminate viral hepatitis. A nationwide serosurvey among adults in 2015 showed 2.9% prevalence for hepatitis B virus (HBV) surface antigen (HBsAg) and 25.9% for antibodies against HBV core antigen (anti-HBc). HBV infection prevalence among children had previously not been assessed. . . Aim. We aimed to assess HBV infection prevalence among children and update estimates for adults in Georgia. . . Metho…
Eurosurveillance latest updates
28.07.2023
. Background. Between May 2015 and February 2022, 77,168 hepatitis C virus (HCV)-infected people in Georgia have been treated through an HCV elimination programme. To project the programme’s long-term impacts, an HCV infection model was initially developed, based on data from surveys among people who inject drugs and a national serosurvey in 2015. . . Aim. Accounting for follow-up surveys in 2021, we validate and update projections of HCV infection prevalence and incidence. . . Method. We assessed the…
Medscape Infectious Diseases
28.07.2023
Managing alcohol-associated hepatitis following hospital discharge requires treating not only the liver disease but also the underlying alcohol use disorder, says a clinical care review. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
21.07.2023
This report describes progress towards hepatitis B control and elimination in the World Health Organization African region.
Medscape Infectious Diseases
15.07.2023
World Hepatitis Day is an opportunity to remind people of the impact of viral hepatitis and to offer information that can help prevent, diagnose, and treat these diseases, said one expert. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
14.07.2023
This report describes new CDC guidance for completing hepatitis C virus testing.
Morbidity and Mortality Weekly Report (MMWR)
1.07.2023
This report describes progress towards achieving hepatitis C viral clearance by 2030.
Medscape Infectious Diseases
28.06.2023
Vaccination rates for hepatitis B virus are slightly lower among patients with psoriasis than among people without psoriasis. . Medscape Medical News
Eurosurveillance latest updates
16.06.2023
Echovirus 11 (E11) has recently been associated with a series of nine neonatal cases of severe hepatitis in France. Here, we present severe hepatitis caused by E11 in a pair of twins. In one of the neonates, the clinical picture evolved to fulminant hepatitis. The E11 genome showed 99% nucleotide identity with E11 strains reported in the cases in France. Rapid genome characterisation using next generation sequencing is essential to identify new and more pathogenetic variants.
Morbidity and Mortality Weekly Report (MMWR)
1.06.2023
This report describes the effectiveness of the Cherokee Nation Health Services hepatitis C elimination program after 5 years.
ProMED
27.05.2023
Hepatitis A -- United StatesOnce again, cases of hepatitis A in San Diego County are on the rise with 28 reported to date and 18 among people experiencing homelessness. The county usually reports about 2 virus cases monthly. While no single outbreak location has been identified, and no specific food or water source found, cases are being reported above baseline.The county is doing its part to take steps to prevent more spread of the disease. The current increase in cases is likely due to person-to-person tr…
ProMED
17.05.2023
Hepatitis A -- CanadaVancouver Coastal Health is notifying people who dined at McDonald's (3695 Lougheed Hwy, Vancouver) about a possible exposure to hepatitis A on the following dates and times:19 Apr 2023 - 8am to 4pm21 Apr 2023 - 12pm - 7:30pm23 Apr 2023 - 8am - 4pm26 Apr 2023 - 8am - 4pm27 Apr 2023 - 7am - 2pm28 Apr 2023 - 7am - 3pm29 Apr 2023 - 7am - 3pm30 Apr 2023 - 8am - 4pm2 May 2023 - 7am - 3pm4 May 2023 - 8am - 4pm8 May 2023 - 6am - 11am9 May 2023 - 6am - 9amAlthough the